Hôpital Femme Mère Enfant
Bron, France
NCT Number: NCT03187327
In this prospective study, patients who underwent vaginal hysterectomy with salpingectomy or salpingo-oophorectomy were included. The objective of this study is to assess the feasibility of prophylactic salpingectomy during vaginal hysterectomy for benign pathology and the prevalence of occult tubal lesions. The hypothesis is that prophylactic salpingectomy during vaginal hysterectomy for benign pathology present a low failure rate and it makes it possible to avoid the appearance of a certain number of ovarian cancers. The prevalence of bilateral salpingectomy with or without ovariectomy and the prevalence of histopathological and immunohistochemical (p53 expression) abnormalities were evaluated.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Bron, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: Day 0
prevalence of bilateral salpingectomy with or without ovariectomy
Hospices Civils de Lyon
Other
Feasibility of Opportunistic Salpingectomy at the Time of Vaginal Hysterectomy for Benign Pathology and Evaluation of Occult Tubal Lesions Prevalence: Preliminary Study
Acronym: FPS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07625137
Adnexal Diseases, Endocrine Gland Neoplasms
Langley, British Columbia, Canada
View Trial DetailsNCT07177144
Ovarian Reserve, Salpingectomy
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03830502
Salpingectomy, Sterilization, Tubal
Bartın, Turkey (Türkiye)
View Trial DetailsNCT02165709
Ovary, Prevention & Control
Chapel Hill, North Carolina, United States
View Trial Details